This inventor holds 2 USPTO granted patents and 2 EPO patents. Top assignees: Université De Bourgogne, Centre Hospitalier Regional Universitaire De Dijon, Institut National De Recherche Pour L'agriculture, L'alimentation Et L'environnement. Active years: 2020-2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:



Years Active: 2020-2022
Title: The Innovative Contributions of Alain Hartmann
Introduction
Alain Hartmann is a notable inventor based in Dijon, France. He has made significant contributions to the field of electrochemical detection, particularly in the identification of mycobacteria and beta-lactamase-producing bacteria. With a total of 2 patents, his work has implications for both medical diagnostics and microbiology.
Latest Patents
Hartmann's latest patents include a method for the electrochemical detection of mycobacteria. This invention relates to a novel process for biological detection via electrochemical analysis methods of the catalytic activity of antigen 85. Additionally, he has developed methods for detecting beta-lactamase-producing bacteria. This electrochemical method allows for the in-vitro determination of the presence of bacteria producing lactamases in a sample that may contain such bacteria.
Career Highlights
Throughout his career, Alain Hartmann has worked with esteemed institutions such as the University of Burgundy and the Centre Hospitalier Regional Universitaire de Dijon. His research has focused on advancing techniques in biological detection, contributing to the fields of microbiology and medical diagnostics.
Collaborations
Hartmann has collaborated with notable colleagues, including Murielle Rochelet and Catherine Neuwirth. Their joint efforts have furthered the development of innovative detection methods in their respective fields.
Conclusion
Alain Hartmann's contributions to the field of electrochemical detection highlight his innovative spirit and dedication to advancing medical diagnostics. His patents and collaborations reflect a commitment to improving the detection of critical bacterial infections.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile